Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

Physicians have responded to the new U.S. Centers for Disease Control and Prevention's clinical guidelines for prescribing opioids

Physicians Respond to New CDC Opioid Guidelines

0
Mainly supportive of guidelines, but concerns include lack of evidence underlying recommendations
For patients requiring dual antiplatelet therapy

ACC: PPI Tx Also Beneficial for Those on Low-Dose Aspirin

0
Gastroprotection with PPI therapy reduced primary GI end point in patients on low-dose aspirin
For infantile hemangiomas

Propranolol for Hemangiomas Doesn’t Impair Infant Growth

0
Only four of 76 patients' growth curves dropped off more than 20 percentiles during therapy
Spending on prescription medications for insured Americans increased about 5 percent in 2015

Spending on Prescription Meds Up About 5 Percent in 2015

0
Increase due to increased medication use and higher prices; increase about half that of 2014
In a case report published online Feb. 28 in the Journal of Clinical Pharmacy and Therapeutics

Non-HIV-Related Kaposi Sarcoma in BRAFi-Treated Patient

0
Patient with history of myasthenia gravis, metastatic melanoma presented with macules on both feet
Inner retina thickness does not change with short- or long-term hydroxychloroquine use

Hydroxychloroquine Doesn’t Alter Inner Retina Thickness

0
No significant change, difference in measurements of inner retinal thickness for short-, long-term use
Intraoperative administration of an otic suspension of ciprofloxacin appears to be safe and effective for children requiring tympanostomy tube placement

Intraoperative Administration of OTO-201 Safe in Tube Placement

0
Otic suspension of ciprofloxacin safe, effective for children undergoing tympanostomy tube placement
Anti-programmed cell death-1 therapy for metastatic melanoma is associated with the development of immune-related cutaneous events

Melanoma Therapy Tied to Cutaneous Adverse Events

0
Anti-programmed cell death-1 therapy tied to lichenoid reactions, eczema, vitiligo
A U.S. Food and Drug Administration safety announcement relating to atrial fibrillation risk associated with bisphosphonates correlated with a reduction in bisphosphonate use

FDA Safety Announcement Affected Bisphosphonate Use

0
Four percent decrease in odds of bisphosphonate use each quarter after safety announcement for a-fib risk
Fewer than half of atrial fibrillation patients at highest risk for stroke are prescribed recommended anticoagulation

Many A-Fib Patients Missing Out on Recommended Anticoagulation

0
Less than half at highest risk take recommended anticoagulants